Gilead Sciences, Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Nov. 6, 2026 and Nov. 9, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.
How the next-report window is calculated
Gilead Sciences, Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed Aug. 6, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.
SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Gilead Sciences, Inc. filed between 37 and 43 days after period end (median 38 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.
Recent filings by Gilead Sciences, Inc.
| Filed | Form | What it is | Document |
|---|---|---|---|
| 13D/A | Amendment to an active-ownership (13D) report | Open SCHEDULE 13D/A filed 2026-08-07 · Index 0001104659-26-092737 | |
| S-3ASR | Automatic shelf registration (well-known seasoned issuer) | Open S-3ASR filed 2026-08-06 · Index 0001104659-26-092110 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended June 30, 2026 | Open 10-Q filed 2026-08-06 · Index 0000882095-26-000031 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-08-04 · Index 0000882095-26-000028 | |
| 13D/A | Amendment to an active-ownership (13D) report | Open SCHEDULE 13D/A filed 2026-05-27 · Index 0001123292-26-000750 | |
| 8-K | Signed a material contract; took on new debt or a similar obligation; other events the company chose to report | Open 8-K filed 2026-05-20 · Index 0001104659-26-064518 | |
| S-8 | Registration of shares for employee benefit plans | Open S-8 filed 2026-05-07 · Index 0000882095-26-000025 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended March 31, 2026 | Open 10-Q filed 2026-05-07 · Index 0000882095-26-000024 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-05-07 · Index 0000882095-26-000022 | |
| 8-K | Reported shareholder vote results | Open 8-K filed 2026-05-04 · Index 0000882095-26-000008 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000510 | |
| 13D/A | Amendment to an active-ownership (13D) report | Open SCHEDULE 13D/A filed 2026-04-28 · Index 0001104659-26-049902 | |
| 8-K | Information shared under Regulation FD; other events the company chose to report | Open 8-K filed 2026-04-28 · Index 0001104659-26-049874 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-001398 | |
| ARS | Annual report delivered to shareholders | Open ARS filed 2026-03-20 · Index 0001308179-26-000108 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-03-20 · Index 0001308179-26-000107 | |
| DEF 14A | Definitive proxy statement for a shareholder meeting | Open DEF 14A filed 2026-03-20 · Index 0001308179-26-000106 | |
| 10-K | Annual report with audited financial statements for the period ended Dec. 31, 2025 | Open 10-K filed 2026-02-24 · Index 0000882095-26-000006 | |
| 13D | Ownership above 5% by an investor who may seek influence | Open SCHEDULE 13D filed 2026-02-23 · Index 0000904454-26-000123 | |
| 8-K | Signed a material contract; information shared under Regulation FD | Open 8-K filed 2026-02-23 · Index 0001104659-26-018314 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-02-12 · Index 0001123292-26-000166 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-02-12 · Index 0001123292-26-000163 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-02-10 · Index 0000882095-26-000003 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-02-05 · Index 0000315066-26-000432 | |
| 8-K | Executive or board change, or executive pay arrangement | Open 8-K filed 2025-11-19 · Index 0001104659-25-113968 |
What Gilead Sciences, Inc.'s 8-Ks were about in the past year
Gilead Sciences, Inc. filed 9 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.
| Item | Meaning | Times |
|---|---|---|
| 9.01 | Financial Statements and Exhibits | 8 |
| 2.02 | Results of Operations and Financial Condition | 4 |
| 1.01 | Entry into a Material Definitive Agreement | 2 |
| 8.01 | Other Events | 2 |
| 7.01 | Regulation FD Disclosure | 2 |
| 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | 1 |
| 5.07 | Submission of Matters to a Vote of Security Holders | 1 |
| 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1 |